Cargando…
MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
Deregulation of fibroblast growth factor receptors (FGFRs) signaling, as a result of FGFR amplification, chromosomal translocation, or mutations, is involved in both initiation and progression of a wide range of human cancers. Clinical data demonstrating the dependence of cancer cells on FGFRs signa...
Autores principales: | Kitowska, Kamila, Gorska-Arcisz, Monika, Antoun, Dima, Zarczynska, Izabela, Czaplinska, Dominika, Szczepaniak, Adrian, Skladanowski, Andrzej C., Wieczorek, Maciej, Stanczak, Aleksandra, Skupinska, Monika, Sadej, Rafal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059549/ https://www.ncbi.nlm.nih.gov/pubmed/33898310 http://dx.doi.org/10.3389/fonc.2021.633410 |
Ejemplares similares
-
p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
por: Zarczynska, Izabela, et al.
Publicado: (2021) -
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
por: Turczyk, Lukasz, et al.
Publicado: (2017) -
FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022) -
Interactions between FGFR2 and RSK2—implications for breast cancer prognosis
por: Czaplinska, Dominika, et al.
Publicado: (2016) -
Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
por: Piasecka, Dominika, et al.
Publicado: (2016)